![Sipuleucel-T [Provenge] – (Immunotherapy for Prostate Cancer)](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%200%200'%3E%3C/svg%3E)
Introduction
Sipuleucel-T, sold under the trade name Provenge, is an immunotherapy used to treat advanced prostate cancer. It is a personalized treatment designed to boost the body’s immune system to target and attack prostate cancer cells, offering a unique approach to managing the disease.
Purpose
- Treats metastatic castration-resistant prostate cancer (mCRPC) in men with minimal or no symptoms.
- Enhances the body’s immune response to slow disease progression.
- Provides a treatment option for patients seeking alternatives to traditional therapies.
How It Works
Sipuleucel-T involves collecting a patient’s immune cells through leukapheresis. These cells are then exposed to a protein that stimulates an immune response against prostate cancer cells. The activated cells are infused back into the patient, enhancing the body’s ability to fight the cancer.
Usage
- Administered in three infusions, spaced approximately two weeks apart.
- Each infusion requires a prior leukapheresis session to collect immune cells.
- The entire treatment process spans about six weeks.
Considerations
- Common side effects include fever, chills, fatigue, and nausea, which are usually mild and temporary.
- Rare but serious side effects include infusion reactions; patients are monitored closely during and after each treatment session.
- This therapy is not suitable for patients with rapidly progressing or symptomatic prostate cancer.
At Crossroads Urology
At Crossroads Urology, Sipuleucel-T is offered as part of a comprehensive approach to advanced prostate cancer care. Our providers work closely with patients to ensure a seamless treatment process, focusing on safety and efficacy.
Conclusion
Sipuleucel-T [Provenge] is an innovative immunotherapy that empowers the immune system to combat prostate cancer, offering new hope for patients with advanced disease. Contact Crossroads Urology today to learn more about this cutting-edge treatment.
